Anaptysbio (ANAB) EBT (2016 - 2026)
Anaptysbio (ANAB) posted EBT of -$52.8 million for Q1 2026, down 206.34% on a QoQ basis from $49.7 million in Q4 2025, and down 34.51% year-over-year from -$80.7 million in Q1 2025.
Anaptysbio (ANAB) EBT (2016 - 2026) Analysis & Trends
Anaptysbio's EBT history runs 11 years deep, the most recent figure standing at -$52.8 million for Q1 2026.
- Quarterly EBT fell 34.51% year-over-year to -$52.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.6 million (up 81.06% YoY) and the FY2025 annual result came in at -$13.1 million, up 91.0% from the prior year.
- EBT was -$52.8 million for Q1 2026 at Anaptysbio, down from $49.7 million in the prior quarter.
- Across five years, EBT topped out at $49.7 million in Q4 2025 and bottomed at -$62.6 million in Q1 2023.
- A 5-year average of -$33.0 million and a median of -$39.3 million in 2025 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT tumbled 94.94% — and 2025, when it soared 328.06%.
- Anaptysbio's EBT stood at -$22.7 million in 2022, then tumbled by 85.63% to -$42.2 million in 2023, then soared by 48.33% to -$21.8 million in 2024, then jumped by 328.06% to $49.7 million in 2025, then plunged by 206.34% to -$52.8 million in 2026.
- Business Quant data shows ANAB's EBT at -$52.8 million in Q1 2026, $49.7 million in Q4 2025, and $15.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - | -52.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.84 Mn |
| Dec 31, 2025 | 49.70 Mn |
| Sep 30, 2025 | 15.11 Mn |
| Jun 30, 2025 | -38.59 Mn |
| Mar 31, 2025 | -39.29 Mn |
| Dec 31, 2024 | -21.79 Mn |
| Sep 30, 2024 | -32.85 Mn |
| Jun 30, 2024 | -46.65 Mn |
| Mar 31, 2024 | -43.94 Mn |
| Dec 31, 2023 | -42.17 Mn |
| Sep 30, 2023 | -37.31 Mn |
| Jun 30, 2023 | -39.85 Mn |
| Mar 31, 2023 | -62.55 Mn |
| Dec 31, 2022 | -22.72 Mn |
| Sep 30, 2022 | -37.62 Mn |
| Jun 30, 2022 | -51.08 Mn |
| Mar 31, 2022 | -56.38 Mn |
| Dec 31, 2021 | -32.13 Mn |
| Sep 30, 2021 | -33.69 Mn |
| Jun 30, 2021 | -26.20 Mn |